Autologous serum eardrops therapy for closing tympanic membrane perforations

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs031180262

Enrollment

Registered

2019-03-13

Start date

2012-03-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

internal otitis

Interventions

Myringoplastiy with autologous serum eardrops

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with tympanic membrane perforation

Exclusion criteria

Exclusion criteria: otitis media or otitis externa

Design outcomes

Primary

Measure	Time frame
Tympanic membrane closure rate	—

Secondary

Measure	Time frame
Hearing improvement	—

Contacts

Public ContactToshinori Kubota

Yamagata University Hospital

t-kubota@med.id.yamagata-u.ac.jp+81-23-628-5380

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026